Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q69Z66

Entry ID Method Resolution Chain Position Source
AF-Q69Z66-F1 Predicted AlphaFoldDB

42 variants for Q69Z66

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3388698894 89 D>V No EVA
rs28150759 106 D>H No EVA
rs28150759 106 D>Y No EVA
rs28150760 114 H>Y No EVA
rs3388673907 184 K>I No EVA
rs32719249 192 A>G No EVA
rs3388684034 196 A>P No EVA
rs3388695899 197 C>F No EVA
rs215737773 201 S>N No EVA
rs237005352 201 S>R No EVA
rs3388692627 222 I>N No EVA
rs3388695305 228 E>D No EVA
rs217161549 231 S>C No EVA
rs243317756 242 T>S No EVA
rs224450610 265 A>T No EVA
rs213180062 271 S>Y No EVA
rs3388698372 276 K>N No EVA
rs28150775 289 A>T No EVA
rs231291503 297 S>N No EVA
rs265520606 312 V>L No EVA
rs253200784 317 T>A No EVA
rs228526853 324 R>T No EVA
rs28150776 342 S>R No EVA
rs3388689085 362 E>D No EVA
rs3388695504 374 R>G No EVA
rs3394408495 445 E>Q No EVA
rs3394690816 448 G>A No EVA
rs3394623575 449 A>P No EVA
rs222962420 470 A>V No EVA
rs254178103 471 A>T No EVA
rs242618628 477 E>D No EVA
rs3388681414 503 W>G No EVA
rs3388691156 511 G>R No EVA
rs228225432 522 M>L No EVA
rs3388696210 586 M>T No EVA
rs261695973 588 E>D No EVA
rs3388692979 681 M>L No EVA
rs3388698304 687 N>K No EVA
rs28150846 701 V>I No EVA
rs28150870 750 V>I No EVA
rs3388681482 759 D>E No EVA
rs221057615 820 M>S No EVA

No associated diseases with Q69Z66

6 regional properties for Q69Z66

Type Name Position InterPro Accession
domain JAB1/MPN/MOV34 metalloenzyme domain 567 - 691 IPR000555
domain SANT/Myb domain 110 - 162 IPR001005
domain SWIRM domain 363 - 461 IPR007526
domain SANT domain 113 - 164 IPR017884
domain Myb domain 110 - 164 IPR017930
domain MPN domain 568 - 700 IPR037518

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
  • Cytoplasm
  • Localizes to the cytoplasm in response to bacterial infection
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

5 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
nucleolus A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
protein-containing complex A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together.

6 GO annotations of molecular function

Name Definition
cysteine-type deubiquitinase activity An thiol-dependent isopeptidase activity that cleaves ubiquitin from a target protein to which it is conjugated.
DNA binding Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
histone binding Binding to a histone, any of a group of water-soluble proteins found in association with the DNA of eukaryotic or archaeal chromosomes. They are involved in the condensation and coiling of chromosomes during cell division and have also been implicated in gene regulation and DNA replication. They may be chemically modified (methylated, acetlyated and others) to regulate gene transcription.
metal ion binding Binding to a metal ion.
metal-dependent deubiquitinase activity An metal-dependent isopeptidase activity that cleaves ubiquitin from a target protein to which it is conjugated.
transcription coactivator activity A transcription coregulator activity that activates or increases the transcription of specific gene sets via binding to a DNA-bound DNA-binding transcription factor, either on its own or as part of a complex. Coactivators often act by altering chromatin structure and modifications. For example, one class of transcription coactivators modifies chromatin structure through covalent modification of histones. A second class remodels the conformation of chromatin in an ATP-dependent fashion. A third class modulates interactions of DNA-bound DNA-binding transcription factors with other transcription coregulators. A fourth class of coactivator activity is the bridging of a DNA-binding transcription factor to the general (basal) transcription machinery. The Mediator complex, which bridges sequence-specific DNA binding transcription factors and RNA polymerase, is also a transcription coactivator.

8 GO annotations of biological process

Name Definition
chromatin remodeling A dynamic process of chromatin reorganization resulting in changes to chromatin structure. These changes allow DNA metabolic processes such as transcriptional regulation, DNA recombination, DNA repair, and DNA replication.
immune system process Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats.
monoubiquitinated histone H2A deubiquitination The removal of the ubiquitin group from a monoubiquitinated histone H2A protein.
pigmentation The accumulation of pigment in an organism, tissue or cell, either by increased deposition or by increased number of cells.
positive regulation of transcription by RNA polymerase II Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
regulation of cell migration Any process that modulates the frequency, rate or extent of cell migration.
regulation of hair follicle development Any process that modulates the frequency, rate or extent of hair follicle development.
regulation of hemopoiesis Any process that modulates the frequency, rate or extent of hemopoiesis.

1 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q5VVJ2 MYSM1 Deubiquitinase MYSM1 Homo sapiens (Human) PR
10 20 30 40 50 60
MEAEEADVDV EGDVAAAAQP GNDESTASVF QDHYLDSTWR RENGCLPWTL DSTISDENRA
70 80 90 100 110 120
IIEKMLLEEE YYLSNKSLPG KFWVNQKEDN KKYTNSLQKS SKAMVDSPAK PASHSVKWTV
130 140 150 160 170 180
EEKELFEQGL AKFGRRWTKI ATLLKSRTVL QVKSYARQYF KNKVKWDVEK ETPTQKSSSD
190 200 210 220 230 240
LQVKNKDDRT KAWAAACLRG SADPCLNAVK IEKLSDDEDV DITDELDELT SQTSQNSGSH
250 260 270 280 290 300
LTLDVPNSKM YTTNQGELCQ EGPLAKSSGE SLQNVKQGEG EACSSSEIAS WAEKQKSTDK
310 320 330 340 350 360
NSAELNEKYN KVVEEHTLHR GEVREEAKHS PSPEPCERQD SSGNEMLLPP CQIEEENHEG
370 380 390 400 410 420
EELKPPEQEV EIDRNVIQEE EKQAIPEFFE GRQTKTPERY LKIRNYILDQ WEICKPKYLN
430 440 450 460 470 480
KTSVRPGLKN CGDVNCIGRI HTYLELIGAI NFGCEQAVYN RPQPLDKVRA ADRKDAEAAY
490 500 510 520 530 540
QLAWRLQSMR TRRRRVRDPW GNWCDAKDLE GQTFEHLSVE EMARRKEEEK CKPIKFSKAS
550 560 570 580 590 600
KLPKSSLDPF QLIPCNFFSE EKQEPFQVKV AAEALLIMNL HAHVSMAEVI GLLGGRYSEA
610 620 630 640 650 660
DKVLEVCAAE PCNSLSTGLQ CEMDPVSQTQ ASETLALRGY SVIGWYHSHP AFDPNPSLRD
670 680 690 700 710 720
IDTQAKYQSY FSRGGAKFIG MIVSPYNRSN PLPYSQITCL VISEEVSPDG TYRLPYKFEV
730 740 750 760 770 780
QQMLEEPQWE LVFEKTRWII EKYRLSNSSV PMDRIFRRDS DLTCLQKLLE CLRKTLSKVA
790 800 810
NCFIAEEFLT QIENLFLSNY KSKEENGLAE EDSTKELFM